26th week of 2012 patent applcation highlights part 46 |
Patent application number | Title | Published |
20120164183 | METHOD FOR DETECTION AND TREATMENT OF ANEURYSMS - The present invention generally concerns the detection and/or treatment of aneurysm in a non-invasive manner. In particular cases, the invention concerns methods and compositions for localizing a labeled composition to the site of an aneurysm for its detection and, in further cases, treatment of the aneurysm. In specific cases, the composition targets a subendothelial component of the aneurysmal wall, such as a smooth muscle cell exposed at the luminal surface of the vessel. In further specific cases, the composition targets an integrin receptor or laminin. | 2012-06-28 |
20120164184 | DPI Formulation Containing Sulfoalkyl Ether Cyclodextrin - An inhalable dry powder formulation containing SAE-CD and an active agent is provided. The formulation is adapted for administration by DPI. The SAE-CD serves as a carrier rather than as an absorption enhancer. The average particle size of the SAE-CD is large enough to preclude (for the most part) pulmonary deposition thereof. Following release from the DPI device, the SAE-CD-containing particles dissociate from the active agent-containing particles in the buccal cavity or throat, after which the active agent-containing particles continue deeper into the respiratory tract. The physicochemical and morphological properties of the SAE-CD are easily modified to permit optimization of active agent and carrier interactions. Drugs having a positive, neutral or negative electrostatic charge can be delivered by DPI when SAE-CD is used as a carrier. | 2012-06-28 |
20120164185 | ORAL NUTRIENT OR MEDICANT CARRIER HAVING INCREASED SURFACE AREA AND ABSORPTION RATE - A nutrient carrier comprises a body which is particularly suited for delivering nutrients via the oral cavity and pharynx. The body of the nutrient carrier comprises or includes a nutrient carrier element or material/composition. For example, the nutrient carrier body may be constructed from a nutrient carrying composition. In other embodiments, the nutrient carrier body may be constructed from a carrier material which carries a desired nutrient (such as a supplement, vitamin, mineral or medication/drug). | 2012-06-28 |
20120164186 | Diketopiperazine Microparticles with Defined Specific Surface Areas - Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m | 2012-06-28 |
20120164187 | BIOACTIVE GLASS FOR USE IN CONDITIONS RELATING TO BONE INFECTIONS - The present invention relates to a bioactive glass having the composition of SiO | 2012-06-28 |
20120164188 | PALIPERIDONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF SUBSTANTIALLY FREE OF IMPURITIES - Provided herein are impurities of paliperidone, 3-[2-[4-[1-(4-fluoro-2-hydroxyphenyl)methanoyl]piperidinyl-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (methanoyl impurity), 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one (dehydroxy impurity) and 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-2-methyl-7,8-dihydro-6H-pyrido[1,2-a]pyrimidin-4,9-dione (9-keto impurity), and processes for preparing and isolating thereof. Provided further herein is a highly pure paliperidone or a pharmaceutically acceptable salt thereof substantially free of methanoyl, dehydroxy and 9-keto impurities, process for the preparation thereof, and pharmaceutical compositions comprising highly pure paliperidone or a pharmaceutically acceptable salt thereof substantially free of methanoyl, dehydroxy and 9-keto impurities. Provided also herein are improved and efficient processes for preparing paliperidone intermediates. | 2012-06-28 |
20120164189 | Lipidic Compositions for Induction of Immune Tolerance - This invention provides a method for inducing immune tolerance toward an antigen comprising the antigen in lipidic particles or lipidic compositions. The lipidic particles are made up of phosphatidylserine and phosphatidylcholine, or phosphatidylinositol and phosphatidylcholine. The lipidic compositions comprise the antigen and O-phospho-L-serine. Administration of these composition results in inducing immune tolerance to the antigen. | 2012-06-28 |
20120164190 | NANOPARTICLE ISOFLAVONE COMPOSITIONS & METHODS OF MAKING AND USING THE SAME - The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein. | 2012-06-28 |
20120164191 | TRANSMUCOSAL DELIVERY DEVICES WITH ENHANCED UPTAKE - The present invention provides methods for enhancing transmucosal uptake of a medicament, e.g., fentanyl or buprenorphine, to a subject and related devices. The method includes administering to a subject a transmucosal drug delivery device comprising the medicament. Also provided are devices suitable for transmucosal administration of a medicament to a subject and methods of their administration and use. The devices include a medicament disposed in a mucoadhesive polymeric diffusion environment and a barrier environment. | 2012-06-28 |
20120164194 | Cosmetic Sampler Sheet - A cosmetic sample sheet is provided which includes cosmetics contained within or under a solid, water-soluble polymeric film, and supported by a substrate sheet. The cosmetics are easily reconstitutable by a consumer to allow the consumer to try different shades or colors of particular cosmetics. | 2012-06-28 |
20120164195 | Cosmetic Films - Personal care products, including cosmetics, are provided as solid, water-soluble polymeric films which adhere to a human integument when wetted. The invention also relates to such films having plural laminated layers, at least two of which possess different cosmetic or therapeutic characteristics. | 2012-06-28 |
20120164196 | SERICIN CATIONIC NANOPARTICLES FOR APPLICATION IN PRODUCTS FOR HAIR AND DYED HAIR - The objective of this patent application is the application/use of sericin nanoparticles m cosmetic formulas for hair care, as an agent that bestows/gives gloss and softness and promotes maintenance of coloration in dyed hair | 2012-06-28 |
20120164197 | Hair Care Compositions Comprising Sucrose Polyesters - A hair care composition having a conditioning active comprising a sucrose polyester having a melting point greater than about 30° C., an IBAR greater than about 5, an IV of about 3 to about 70, and an aqueous carrier, and may further comprise optional ingredients including but not limited to, silicone, cationic polymers, and fatty alcohols. The composition can also comprise a blend of sucrose polyesters, wherein the blend comprises two or more sucrose polyesters, wherein at least one sucrose polyester has a melting point greater than about 30° C., an IBAR greater than about 5, an IV of about 3 to about 70, and at least one sucrose polyester has an IBAR between about 1 and about 8, and an IV between about 1 and about 135, and wherein the sucrose polyester blend has an IBAR of at least 5 and an IV of about 1 and about 135. | 2012-06-28 |
20120164198 | Shampoo Containing a Gel Network and a Non-Guar Galactomannan Polymer Derivative - Shampoo compositions comprise (a) from about 5% to about 50% of one or more detersive surfactants; (b) a dispersed gel network phase comprising: (i) at least about 0.05% of one or more fatty amphiphiles; (ii) at least about 0.01% of one or more secondary surfactants; and (iii) water; (c) at least about 0.05% of a galactomannan polymer derivative with a net positive charge and having a mannose to galactose ratio of greater than 2:1 on a monomer to monomer basis, wherein the galactomannan polymer derivative has: (i) a molecular weight from about 1,000 to about 10,000,000; and (ii) a cationic charge density from about 0.7 meq/g to about 7 meq/g; and (d) at least about 20% of an aqueous carrier; all by weight of the shampoo composition. | 2012-06-28 |
20120164199 | CHEMICALLY AND/OR BIOLOGICALLY REACTIVE COMPOUNDS - This disclosure provides novel compositions comprising an inorganic and organic compound, which provides a means for the indirect attachment of a reactive species, such as an organic reactive molecule, within a binder polymer matrix. Such compositions provide a hydrophilic nanoscale domain that is uniformly dispersed within the polymer matrix. The nanoscale domain comprises inorganic particles having a nanoscale dimension. Such compositions can enhance the performance potential of the re-active species within the polymer material. The polymer composite that results from the introduction of such reactive species into a polymer matrix provides a self-decontaminating feature. The reactive species include those that are capable of associating with a halogen to form a complex that is active in decontamination of chemical or biological agents. | 2012-06-28 |
20120164200 | SUBSTRATES COMPRISING FROTHED BENEFIT AGENTS AND THE METHOD OF MAKING THE SAME - The present invention provides a nonwoven substrate comprising a fibrous web defining a surface; and a layer of a benefit agent wherein said benefit agent is selected from an additive composition, an enhancement component and combinations thereof; wherein said benefit agent is frothed and bonded to the fibrous web surface through a creping process. Additionally, the present invention provides for a method of creping a nonwoven substrate and also provides for a nonwoven substrate comprising an adhesive film of an aqueous, frothed, benefit agent. | 2012-06-28 |
20120164201 | METHOD OF USING COLLOIDAL SILVER AND GOLD ANTI-MICROBIAL ITEMS TO CREATE CLEAN ZONES THEREWITH - Gelatinous foam, coated paper, fabric, and polymer materials combined with the Colloidal Silver or Gold additive to formulate products with anti-microbial surfaces which will then be installed through a process determined by the owner/operator of a multi-person/multi-use facility (with input from the end user) to create anti-microbial areas within the facility. Embodiments of the present invention can be formed from polymer materials with silver or gold additives for creating bacteria-free anti-microbial areas, known as a Clean Zone™, in multi-use or multi-person facilities, such as gyms, hotels, hospitals, doctors' offices, food courts, restaurants, cruise ships, buses, and airplanes. The various embodiments include coated polymer sheets, polymer trays, bamboo and/or cotton towels, rugs and fabric, polymer foam, or polymer mats containing nano-silver or nano-gold in an scheduled and organized manner (with input/requests from the customer) to create permanent or semi-permanent anti-microbial surfaces. | 2012-06-28 |
20120164202 | ANTIMICROBIAL COLLOIDAL SILVER AND GOLD PRODUCTS AND METHOD OF MAKING SAME - Gelatinous foam, coated paper, fabric, and polymer materials combined with the Colloidal Silver or Gold additive to formulate products with antimicrobial surfaces. Some embodiments of the present invention can include gelatinous materials selected from a group consisting of thermosetting polymer, Styrene-Ethylene-Butadiene-Styrene polymer (SEBS), Thermoplastic Elastomer (TPE), and Polyurethane (PU) gelatin with and without a raised geometry on an outer surface and in any shape. The various embodiments include coated polymer sheets, polymer trays, bamboo and/or cotton towels and fabric, polymer foam, or polymer mats containing nano-silver or nano-gold in an scheduled and organized manner (with input/requests from the customer) to create permanent or semi-permanent anti-microbial surfaces. | 2012-06-28 |
20120164203 | PROCESS FOR PREPARATION OF STABLE, MICROENCAPSULATED AND SUSTAINED RELEASE BIOCIDAL ACTIVES AND COMPOSITION THEREOF - Disclosed herein is a process for the preparation of a stable sustained-release biocidal composition containing microencapsulated biocide and wherein the process comprises the steps of: (i) adsorbing the biocide onto an inert carrier by grinding to attain the required particle size and wherein the ratio of biocide; inert carrier is in the range of about 1:99 to about 99:1 (ii) optionally coating with an appropriate amine or imine compound or a water resistant film forming polymer and dispersing the resultant biocide encapsulated inert carrier in an aqueous medium in the presence of suitable dispersing agent (iii) adding at least one thickening agent to re-disperse the encapsulated biocide containing partial amount of non-encapsulated biocide if any and (iv) preparing an aqueous or solvent based sustained release biocide dispersion. Also disclosed is a stable, sustained-release biocidal composition prepared by such process and uses thereof. | 2012-06-28 |
20120164204 | ENCAPSULATION USING WAX-TYPE SUBSTANCES - Method for producing stable capsules which comprises the steps of providing a first component comprising a wax-like substance and a second component comprising a substance to be encapsulated, dissolved or dispersed in a liquid medium, homogeneously mixing the first and second components, dispersing the mixture in an aqueous solution using at least one dispersion auxiliary at a temperature above the melting point of the wax-like substance to prepare a microemusion, and cooling and diluting the microemulsion. | 2012-06-28 |
20120164205 | COMPOSITIONS AND METHODS FOR CONTROL OF INSECT INFESTATIONS IN PLANTS - The present invention is directed to controlling pest infestation by inhibiting one or more biological functions in an invertebrate pest. The invention discloses methods and compositions for use in controlling pest infestation by feeding one or more different recombinant double stranded RNA molecules to the pest in order to achieve a reduction in pest infestation through suppression of gene expression. The invention is also directed to methods for making transgenic plants that express the double stranded RNA molecules, and to particular combinations of transgenic pesticidal agents for use in protecting plants from pest infestation. | 2012-06-28 |
20120164206 | Bacteriostatic Tissue Product - A tissue product comprising an additive composition onto at least the surface of a fibrous article in order to increase the surface potential of the article, while retaining or improving manufacturing efficiency is disclosed. The additive composition comprises a bacteriostatic component and more preferably a water-soluble adhesive component and a bacteriostatic component. In some aspects, the additive may also contain additional water-soluble modifier components. Tissue products according to the present disclosure can attract and trap negatively charged matter, such as bacteria, into the tissue web. As such, tissue products can pickup bacteria from a surface and substantially hold the bacteria in the sheet to help prevent spreading bacteria to other surfaces. | 2012-06-28 |
20120164207 | Degradable networks for sustained release and controlled release depot drug delivery applications - Provided herein is a controlled release and/or sustained release depot drug delivery system, comprising, a biodegradable polymer coating and an API coated with the biodegradable polymer coating, wherein a quantity of API coated with biodegradable polymer is effective to be released from the biodegradable polymer coating over a prolonged period of time. | 2012-06-28 |
20120164208 | CHITOSAN HYDROGEL DERIVATIVES AS A COATING AGENT WITH BROAD SPECTRUM OF ANTIMICROBIAL ACTIVITIES - The present invention relates to water soluble quaternized chitosan derivatives which form hydrogel matrix with broad antimicrobial properties for the protection and coating of medical device. Hydrogel is attractive as an antimicrobial coating since its hydrophilicity intrinsically prevents the reversible nonspecific attachment of microbes. | 2012-06-28 |
20120164210 | PHOTODYNAMIC THERAPEUTIC AGENT HAVING CELL-SPECIFIC ACTIVE ACCUMULATION PROPERTIES - The present invention relates to a cancer-cell-specific polymer compound containing a photosensitizer for photodynamic therapy and having a surface to which an antibody against a cancer-cell-specific antigen binds. An object of the present invention is to provide a photodynamic therapeutic agent that can reach the cancer tissue at a low concentration via active targeting and makes complications (e.g., sunlight hypersensitivity) associated with photodynamic therapy unlikely to occur. | 2012-06-28 |
20120164211 | COMPOSITIONS AND METHODS FOR TREATING LYMPHOMA - The present invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of leukemias, including acute lymphoblastic leukemia (ALL). The methods involve the administration of liposome-encapsulated vinca alkaloids, e.g., vincristine, in combination with dexamethasone to a mammal with a leukemia. | 2012-06-28 |
20120164212 | STEM CELL BEACON - The invention relates to methods and compositions for selectively directing stem cells to a target tissue within a subject using a system that employs one or more vectors that contain a gene switch/biosensor, a tissue-specific promoter, a gene encoding a stem cell-attracting chemokine, and a gene amplification system. In one embodiment, a stem cell-attracting chemokine is expressed in damaged tissue using a stimulus-responsive vector system. The stimulus can be a physiological stimulus associated with cell injury, such as hypoxia or elevated glucose levels, for example. Expression of the chemokine increases the trafficking of stem cells to the damaged tissue. | 2012-06-28 |
20120164213 | TIME-RELEASE AND MICRO-DOSE FORMULATIONS FOR TOPICAL APPLICATION OF ESTROGEN AND ESTROGEN ANALOGS OR OTHER ESTROGEN RECEPTOR MODULATORS IN THE TREATMENT OF DRY EYE SYNDROME, AND METHODS OF PREPARATION AND APPLICATION - A topical application formulation of estrogen and estrogen analogs or other estrogen receptor modulators is disclosed for the treatment of primary or secondary dry eye syndrome (also known as keratoconjunctivitis sicca (KCS)). Preferred formulations include 17-β-estradiol and its derivatives in lipid, liposomes, polymers, or aqueous or non-aqueous vehicles for the topical treatment of the ocular surface tissues particularly as time-release or micro-dose formulations. These formulations may also be useful in treating other conditions where KCS may occur, such as post-operative refractive surgery and corneal transplant patients. | 2012-06-28 |
20120164214 | LIPOSOMAL COMPOSITIONS AND USES OF SAME - Compositions comprising liposomes composed of whole cell membrane fraction are provided. The liposomes may be attached to, or encapsulate a pharmaceutical agent. Also provided are methods of generating and using these lipospmes. | 2012-06-28 |
20120164215 | TOPICAL CO-ENZYME Q10 FORMULATIONS AND METHODS OF USE - Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals. | 2012-06-28 |
20120164216 | PHARMACEUTICAL COMPOSITION OF DULOXETINE OR PHARMACEUTICALLY - The invention relates to a taste masked pharmaceutical composition comprising duloxetine or pharmaceutically acceptable salts thereof. The invention also relates to processes for the preparation of such compositions. The invention further discloses an inclusion complex comprising duloxetine or pharmaceutically acceptable salts thereof with one or more cyclodextrin or derivatives thereof. | 2012-06-28 |
20120164217 | SCENTED CAPSULES - The present invention relates to new scented hard capsules, a process for their manufacture and use of such capsules particularly but not exclusively for oral administration to humans or animals of products such as pharmaceuticals or cosmetics. | 2012-06-28 |
20120164218 | SOLID DOSAGE FORMS OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE AND METHOD OF MAKING THE SAME - Monolayer, bilayer and trilayer solid dosage forms of a combination of valsartan, amlodipine and hydrochlorothiazide are made. | 2012-06-28 |
20120164219 | PERORAL TABLET FOR BOWEL CLEANSING - To provide a peroral tablet for bowel cleansing which leaves no remains in the intestinal tract after bowel cleansing, which exhibits a dissolution property equivalent to that of conventional sodium phosphate-containing tablets including crystalline cellulose, and which is a small-size agent readily taken by a subject. | 2012-06-28 |
20120164220 | Encased Tamper Resistant Controlled Release Dosage Forms - In certain embodiments, the present invention is directed to a solid controlled release dosage form comprising: a core comprising a first portion of an opioid analgesic dispersed in a first matrix material; and a shell encasing the core and comprising a second portion of the opioid analgesic dispersed in a second matrix material; wherein the amount of opioid analgesic released from the dosage form is proportional within 20% to elapsed time from 8 to 24 hours, as measured by an in-vitro dissolution in a USP Apparatus 1 (basket) at 100 rpm in 900 ml simulated gastric fluid without enzymes (SGF) at 37 C. | 2012-06-28 |
20120164221 | COMBINATIONS OF HMG-COA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPERLIPIDEMIA ONCE A DAY AT NIGHT - The present invention relates to solid pharmaceutical combinations for oral administration comprising nicotinic acid or a nicotinic acid compound or mixtures thereof in an extended release form and an HMG-CoA reductase inhibitor, which are useful for altering lipid levels in subjects suffering from, for example, hyperlipidemia and atherosclerosis, without causing drug-induced hepatotoxicity, myopathy, or rhabdomyolysis. | 2012-06-28 |
20120164222 | NOVEL COMPOUNDS AND COMPOSITIONS AND METHODS OF USE - Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid. | 2012-06-28 |
20120164223 | RAPIDLY DISINTEGRATING, SOLID COATED DOSAGE FORM - Rapidly disintegrating, solid coated dosage form comprising a solid core consisting of at least 60% by weight of an auxiliary mixture, up to 40% by weight of at least one active ingredient, and optionally further auxiliaries, coated with at least one film coating comprising completely or partially hydrolyzed, rapidly water-soluble polyether-vinyl ester graft polymers, methods for the production thereof, and their use. | 2012-06-28 |
20120164224 | Hemostatic Preparation Containing an Extract of Golden Moss - The present invention relates generally to agents and devices for promoting hemostasis and, more particularly, to an extract of a plant-based “Traditional Chinese Medicinal” product and devices incorporating such agents for the delivery thereof to bleeding wounds. | 2012-06-28 |
20120164225 | BONE GRAFT MATERIALS AND METHODS - Compositions, materials, methods and kits for bone grafting are described. In some embodiments, a bone graft composition includes about 15% to about 20% by weight collagen, about 55% to about 70% by weight bioactive glass, and about 15% to about 30% by weight a calcium phosphate. The bioactive glass and the calcium phosphate together are about 80% to about 85% by weight of the bone graft composition. In some embodiments, a bone graft composition includes a collagen matrix and a plurality of bioactive glass particulates dispersed throughout the collagen matrix. The collagen matrix is about 20% to about 60% by weight of the bone graft composition, and the bioactive glass is about 40% to about 80% of the bone graft composition. In some embodiments, a majority of the bioactive glass particulates are about 53 μm to about 425 μm in size. | 2012-06-28 |
20120164226 | Compositions and Methods for Improving Prognosis of a Human with Subarachnoid Hemorrhage - The described invention provides a pharmaceutical composition, delivery system and a method for treating a delayed complication associated with a brain injury in a mammal and improving its prognosis in a mammal by implanting a therapeutically effective amount of the pharmaceutical composition containing a voltage-gated calcium channel blocker and a pharmaceutically acceptable carrier into a predetermined location in the brain, which reduces signs or symptoms of at least one delayed complication associated with brain injury. | 2012-06-28 |
20120164227 | NEW GRANULATING PROCESS AND THUS PREPARED GRANULATE - The present invention relates to a process for manufacturing microcrystalline ezetimibe containing granulate, wherein a) ezetimibe is dissolved; b) the dissolved ezetimibe is precipitated with water, which if necessary contains pharmaceutical excipients, preferably lauryl-sulfate derivatives, and c) granulates are formed from the obtained suspension by spraying the suspension onto pharmaceutical excipients. A further aspect of the present invention is the granulate obtained by the present process and the pharmaceutical composition containing such granulate. | 2012-06-28 |
20120164228 | NOVEL PHARMACEUTICAL FORMULATIONS TO PREVENT THE MISUSE OF MEDICINAL DRUGS - Granules having a solid core on which an active ingredient is supported, the core being chosen preferably from among insoluble supports, the granules also having, supported on said the core, the following compounds: one or more colouring agents, one or more metallic pigments, one or more gas-releasing compounds, and optionally one or more embittering agents. | 2012-06-28 |
20120164229 | DEPOT SYSTEMS COMPRISING GLATIRAMER OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF - The present invention provides long acting parenteral pharmaceutical compositions comprising a therapeutically effective amount of glatiramer. In particular, the present invention provides a long acting pharmaceutical composition comprising a therapeutically effective amount of glatiramer acetate in depot form suitable for administering at a medically acceptable location in a subject in need thereof. The depot form is suitable for subcutaneous or intramuscular implantation or injection. | 2012-06-28 |
20120164230 | Soluble Nanoparticles as Delivery Systems for Prodrugs - Compounds and methods are disclosed in which a prodrug can be delivered in an elevated oxidative state to cells by means of graphitic nanoparticles to which the prodrug is attached by a hydrophilic polymer and which have been made soluble by a hydrophilic polymer, such as PEG. The graphitic nanoparticle may be a single walled carbon nanotube (SWNT). The prodrug may be a DNA-binding metal-based drug. Exemplified is a platinum(IV) complex c,c,t-[Pt(NH | 2012-06-28 |
20120164231 | Synthesis Of Oxygen Carrying, Turbulence Resistant, High Density Submicron Particulates - An artificial oxygen carrier (AOC) for use in the body. A first gas permeable first shell encloses an oxygen carrying agent. The first shell has a second oxygen carrying agent surrounding it, and there is a second gas permeable shell enclosing the second agent. The concentric shells are not subject to turbulent breakup, or chemical decomposition, do not release the agents. | 2012-06-28 |
20120164232 | CONSTRUCT COATED WITH VIRUS COAT-CONSTITUTING PROTEIN AND METHOD FOR PRODUCING SAME - Disclosed is a construct comprising a virus coat protein usable as a carrier for drug delivery adaptable to various drugs. Specifically disclosed is a construct coated with a virus coat protein, comprising a virus coat protein and a construct coated therewith, wherein the virus coat protein is attached to the surface of the construct to form a layer of the protein thereon. | 2012-06-28 |
20120164233 | PULSATILE RELEASE PHARMACEUTICAL FORMULATION OF DEXLANSOPRAZOLE - The present invention relates to a pulsatile-release pharmaceutical formulation of dexlansoprazole composed of a single type of enteric coated pellets and the process for the preparation thereof. | 2012-06-28 |
20120164234 | COMPOSITIONS AND METHODS FOR SEPARATING, CHARACTERIZING AND ADMINISTERING SOLUBLE SELENOGLYCOPROTEINS - The invention relates to soluble selenium compositions and methods of production, separation and purification thereof. In particular the present invention provides methods of preparing water soluble selenoglycoproteins (e.g., via extracting selenoglycoproteins from selenium enriched yeast), methods of supplementing a selenium deficient composition via admixing water soluble selenoglycoproteins with the selenium deficient composition, compositions comprising the water soluble selenoglycoproteins and methods of administering the same. | 2012-06-28 |
20120164235 | Hydrogel formulation comprising oxidative reductive potential water - The present invention relates to a hydrogel formulation containing an oxidative reduction potential (ORP) water solution and a gelling agent. The invention further provides a method for treating or preventing a condition in a patient comprising topically administering to a patient a therapeutically effective amount of a hydrogel formulation comprising an oxidative reductive potential solution and a gelling agent. A method for promoting wound healing in a patient is also provided. | 2012-06-28 |
20120164236 | DISINFECTANT COMPOSITION AND DISINFECTING METHOD - The present invention relates to a disinfectant composition containing the following components (A) to (D): component (A): a zinc compound, component (B): a chelate compound represented by the following general formula (b1) or (b2), component (C): hydrogen peroxide or a peroxide that releases hydrogen peroxide in water, and component (D): an organic peroxy acid precursor that generates an organic peroxy acid by reacting with the component (C). According to the present invention, a disinfectant composition and a disinfecting method can be provided that enable the effective elimination of gram negative bacteria adhered to textile products, and particularly cotton products. | 2012-06-28 |
20120164237 | ENHANCED ACTIVITY HYDROGEN PEROXIDE DISINFECTANT - An aqueous disinfecting solution having a pH of from about 0.5 to about 6 consists essentially of hydrogen peroxide in a concentration of from about 0.05 to about 8 w/w % of the total solution, at least one anionic surfactant in a concentration of from about 0.02 to about 8 w/w % of the total solution, and at least one additional ingredient chosen from benzyl alcohol, an alcohol comprising one to six carbon atoms, and mixtures thereof, in a concentration of from about 0.1 to about 10 w/w % of the total solution. | 2012-06-28 |
20120164238 | METHODS OF DETECTING COLORECTAL CANCER - A method of detecting a predisposition to, or the incidence of colorectal cancer in a faecal sample comprises, in a first step (a), detecting the presence of blood in the faecal sample, wherein detection of the presence of blood is indicative of a predisposition to, or the incidence of colorectal cancer. The method additionally comprises, in second step (b), detecting an epi-genetic modification in the DNA contained within the faecal sample, wherein detection of the epigenetic modification is indicative of a predisposition to, or the incidence of colorectal cancer. Based upon a positive result obtained in either (a) or (b) or in both (a) and (b) a predisposition to, or the incidence of colorectal cancer is detected. Related methods and kits involve detecting an epigenetic modification in a number of specific genes. | 2012-06-28 |
20120164239 | COMPOSITION AND METHOD FOR TREATING WOOD-BASED MATERIAL AND WOOD-BASED MATERIAL TREATED WITH COMPOSITION - A composition for treating wood-based material including at least one C | 2012-06-28 |
20120164240 | ENRICHED A. BLITOIDES COMPOSITIONS AND USES THEREOF - Embodiments of the inventions described herein provide, among other things, enriched | 2012-06-28 |
20120164241 | BOEHMERIA EXTRACT AND ITS USE IN TREATING LIVER DISEASES - A pharmaceutical composition prepared from a | 2012-06-28 |
20120164242 | NOVEL METHODS FOR MODULATING MELANIN PRODUCTION - Methods are provided for modulating pigmentation and melanin production by administering an extract of | 2012-06-28 |
20120164243 | Compositions and Methods for Improving Mitochondrial Function and Treating Neurodegenerative Diseases and Cognitive Disorders - Provided are compositions comprising compounds or precursors to compounds which may be used for a variety of therapeutic applications including, for example, treating and/or preventing a disease or disorder related to reduced or inadequate mitochondrial activity, including aging or stress, diabetes, obesity, and neurodegenerative diseases. The compounds relate generally to urolithins and precursors thereof, including but not limited to ellagitannins and urolithin A. In certain embodiments the compositions are presented in or as food products or nutritional supplements. These same compounds and compositions can also be used advantageously in generally healthy individuals to increase or maintain metabolic rate, decrease percent body fat, increase or maintain muscle mass, manage body weight, improve or maintain mental performance (including memory), improve or maintain muscle performance, improve or maintain mood, and manage stress. | 2012-06-28 |
20120164244 | COMBINATION OF PROANTHOCYANIDINS AND CENTELLA ASIATICA FOR THE TREATMENT OF ATHEROSCLEROSIS - The invention relates to a preparation for medical purposes and more specifically to a preparation consisting of the combination of proanthocyanidins such as Pycnogenol or grape seeds and | 2012-06-28 |
20120164245 | METHOD OF TREATMENT OF NEURODEGENERATIVE OR NEURO-MUSCULAR DEGENERATIVE DISEASES AND THERAPEUTIC AGENT TO TREAT THE SAME - Use of high doses above 1 gm per day of ascorbic acid or the derivatives thereof for the treatment of neurodegenerative and neuro-muscular degenerative diseases and disorders, in particular amytrophic lateral sclerosis, multiple sclerosis, alzheimer's disease, parkinson's disease, and muscular dystrophy is disclosed. Preferably the dose includes mannitol which facilitates the delivery of ascorbic acid to the target cells in the brain. Still further the said dose includes zinc citrate for preventing formation of kidney stones. Dose compositions for various routes of application such as oral, intravenous, intramuscular, nasal and in the form of transdermal patches are discussed. | 2012-06-28 |
20120164246 | One or more of Vigna marina, Cocos nucifera L. or Terminalia catappa L. extracts for treating wounds, skin disorders and hair loss - Biologically active extracts of one or more | 2012-06-28 |
20120164247 | MEDICINAL AND HERBAL COMPOSITION AND USES THEREOF - The subject application provides compositions and methods for treating HIV/AIDS and other diseases. The compositions contain herbs or extracts of herbs found in Kenya, and naltrexone. | 2012-06-28 |
20120164248 | Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs - A wound healing formulation is disclosed using an oil in water emulsion that uses unpolluted forms of water derived from botanical sources and yeast derived wound healing factors together with natural based disinfectants derived from thymol. As opposed to conventional water supplies, the water derived from botanical sources has factors that contribute to the healing process. The formulation is non-occlusive, allowing the skin to breathe, and contains pigments that conceal the wound. | 2012-06-28 |
20120164249 | CHINESE HERBAL MEDICINE COMPOSITION USED FOR ANTIINFLAMMATION, DETUMESCENCE AND ACESODYNE, AND PREPARATION METHOD AND USE THEREOF - A Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, comprising first type of medicinal materials and second type of medicinal materials. The first type of medicinal materials include Rhizoma Bletillae, Cortex Cinnamomi, Radix Angelicae Formosanae, Radix Angelicae Sinensis, Paeonia Lactiflora, Rhizoma Notopterygii, Radix Linderae, Glycyrrhizae, Radix Angelicae Pubescentis, and Radix Et Rhizoma Rhei. The second type of medicinal materials is one, two or three selected from the group cosisting of | 2012-06-28 |
20120164250 | METHOD FOR ANTI-OXIDATION, INHIBITING ACTIVITY AND/OR EXPRESSION OF MATRIX METALLOPROTEINASE, AND/OR INHIBITING PHOSPORYLATION OF MITOGEN-ACTIVATED PROTEIN KINASE USING FLEMINGIA MACROPHYLLA EXTRACT - A method for inhibiting at least one selected from the group consisting of oxidation, the activity of matrix metalloproteinase (MMP), the expression of matrix metalloproteinase, and the phosphorylation of mitogen-activated protein kinase (MAP kinase) in a mammal, comprising administrating to the mammal an effective amount of a | 2012-06-28 |
20120164252 | SUPPLEMENT COMPRISING BLACKCURRANTS OR BOYSENBERRIES - The present invention relates to a dietary supplement comprising one or more of processed whole blackcurrants, processed whole boysenberries, one or more natural component extracted from blackcurrants, and one or more natural component extracted from boysenberries. The dietary supplement is particularly, but not exclusively, suitable for animals. | 2012-06-28 |
20120164253 | ANTI-INFLUENZA VIRAL COMPOSITION CONTAINING BARK OR STEM EXTRACT OF ALNUS JAPONICA - The present invention relates to an antiviral composition comprising an | 2012-06-28 |
20120164254 | SYSTEMS AND METHODS FOR BLADDERLESS TIRE CURING - A system for curing tires that does not require a traditional bladder is described. The system has top and bottom assembly rings that are coupled to modified mold rings. The bottom assembly ring has a curing medium delivery system, which has ports and a diverter that disperses the curing medium thereby reducing the momentum of the curing medium striking a liner the tire being cured. The system is adapted for easy installation to existing center post presses. | 2012-06-28 |
20120164255 | CUTTER HEAD HOLDER OF AN UNDERWATER GRANULATOR - A cutter head holder for blades of an underwater granulator for granulating pellets from a plastic melt that emerges from a perforated plate into a process chamber of a housing of an underwater granulator. | 2012-06-28 |
20120164256 | PRINT HEAD ASSEMBLY AND PRINT HEAD FOR USE IN FUSED DEPOSITION MODELING SYSTEM - A print head assembly that includes a print head carriage and multiple, replaceable print heads that are configured to be removably retained in receptacles of the print head carriage. The print heads each include a cartridge assembly and a liquefier pump assembly retained by the cartridge assembly. | 2012-06-28 |
20120164257 | DEVICE FOR THERMOFORMING A PLASTIC FILM - A thermoforming device heats a plastic film to a substantially uniform temperature, in order to impart a curved shape to said film. The device includes a chamber, the internal pressure of which is variable and which is closed by the film, a system for measuring a sag in the film arranged outside the chamber and opposite said film, and a system for heating the film. The heating system includes a hot air blowing unit which is suitable for producing a hot airflow flowing parallel to the film between two opposite edges of said film. | 2012-06-28 |
20120164258 | DEVICE FOR BLOWING AND STRETCHING A PLASTIC PARISON FOR OBTAINING A CONTAINER | 2012-06-28 |
20120164259 | Dry-cast concrete block molding machine - A dry-cast concrete block molding machine for molding concrete blocks. The machine includes a weigh hopper system which senses when the proper amount of concrete, as determined by the weight thereof, has been placed in the weigh hopper to dump the weigh hopper. The machine also includes end plates in the mold box thereof which may be interchanged so that the configuration of the concrete block may be easily changed. The machine also includes a conveyor system which not only conveys mold trays into the mold box of the machine but which also is used to push the molded block outwardly from the compaction chamber of the mold box when the block has been molded. | 2012-06-28 |
20120164260 | PIPE PROCESSING APPARATUS - Pipe processing apparatus comprising a stamping tool for applying peripheral embossing and/or peripheral stamping to a pipe end section of a pipe, characterised in that the pipe processing apparatus comprises a template which has a pipe sleeve which can be inserted in the pipe end section and having at least one contact surface region, wherein the contact surface region is designed and equipped to limit the insertion depth of the pipe sleeve by means of positive locking between the contact surface region and at least one part region of a pipe end of the pipe end section facing the contact surface region and to position the stamping tool in a work position on the pipe end section as a stamping tool counter-surface. | 2012-06-28 |
20120164261 | APPARATUS AND METHOD FOR RELEASING A LENS MOLDED IN A CAVITY BETWEEN POSTERIOR AND ANTERIOR MOLD SECTIONS - An apparatus and method for releasing a lens moulded in a cavity between posterior and anterior mould sections and adhered thereto. A post is configured to support a flange of the posterior section whilst the anterior section remains spaced from the post. Posterior section is compressed between a pin applied to an outer concave surface of the posterior section and the post, thereby initially releasing peripheral regions of the posterior section and subsequently the remaining portions thereof. Upon separation, the anterior section together with the lens drops onto the post so that its outer convex surface rests on the post. A collar unit with gas channels presses against a flange of the anterior section whilst blowing jets of gas towards an interface between a “monomer” ring formed around the lens. In this manner, initially the “monomer” ring and then peripheral regions of the lens are separated from the anterior section. | 2012-06-28 |
20120164262 | MOLD FOR FORMING A PRODUCT WITH A THROUGH HOLE - A mold includes a female mold defining a receiving space and a male mold including a body and a core protruding from the body. The male mold and the female mold cooperatively define a molding cavity for forming a molding product. The core includes a distal end portion inserted into the receiving space. The distal end portion is configured for forming a through hole of the molding product. The female mold includes two protruding ribs arranged at a parting line between the female mold and the core. The protruding ribs of the female mold is located on opposite sides of the distal end portion, and extend around the distal end portion. The core includes two protruding ribs formed on the distal end portion at the parting line between the female mold and the core. The protruding ribs of the core extend around the distal end portion. | 2012-06-28 |
20120164263 | METHOD FOR CHANGING A MOLD - Disclosed is a moulding device for a machine for producing containers consisting of a thermoplastic material by forming a pre-heated preform using at least one pressurized fluid. The device includes: two mould carriers mounted in such a way that they can move in relation to each other about a rotational axis, between an open position and a closed position; two mould halves that each have a half-impression, are carried by a mould carrier, and are respectively mounted in the associated mould carrier; and fixing element that can dismountably fix each mould half, in its mounted position, to the mould carrier. The element for fixing each mould half to the mould carrier, which are mounted in such a way that they can move at least between a fixing position and a release position, can be controlled as they move between the positions when the mould carriers are in the closed position. | 2012-06-28 |
20120164264 | HERBAL COMPOSITION FOR WEIGHT MANAGEMENT - Herbal extracts composition suitable for weight management in mammals is disclosed. The composition comprises a mixture of | 2012-06-28 |
20120164265 | Dietary Method for Modulating Glucose Metabolism - The invention provides a method for treating abnormal glucose metabolism and insulin resistance in an animal by feeding a diet comprising high protein and moderate amounts of carbohydrate and fat. The invention also provides a method for treating conditions associated with insulin resistance or decreased longevity by feeding an animal such diets. | 2012-06-28 |
20120164266 | PROCESS FOR THE TOTAL OR PARTIAL REPLACEMENT OF TALC IN CHEWING GUM - Disclosed is a method of production of chewing gum including a step of mixing the ingredients, a step of extrusion of the mixture, a step of dusting with a dusting powder, a rolling step and a forming-cutting step, wherein the dusting powder includes a pulverulent composition containing from 28% to 0.1%, preferably from 25% to 1% of particles of diameter below 75 μm and of hygroscopicity between 0.01 and 5%, the pulverulent composition including at least one polyol. Also disclosed is the chewing gum obtained by application of the method. | 2012-06-28 |
20120164267 | METHOD FOR OBTAINING CHEWING GUM, IN WHICH TALC IS REPLACED WITH AGGLOMERATES OF CRYSTALS - A chewing gum production method includes a step in which the ingredients are mixed together, a mixture-extrusion step, a dusting step using a dusting powder, a sheeting step and a shaping/cutting step. The dusting powder includes a powder composition of agglomerates of crystals, the powder composition including at least one polyol. The resulting chewing gum is also described. | 2012-06-28 |
20120164268 | Confectionery Composition - The present invention relates to a confectionery composition which is able to provide a new and improved flavour and texture experience for a consumer. The confectionery composition has interconnected pores therein which contain a fill material. | 2012-06-28 |
20120164269 | Composition for making deer antler wine, method for making deer antler wine by using the composition, and deer antler wine made by the method - A composition for making a deer antler wine is disclosed, which includes: a deer antler powder in an amount of 6-24 parts by weight; grapes in an amount of 15.5-62 parts by weight; tea in an amount of 4.5-18 parts by weight; and a ginseng in an amount of 6-24 parts by weight. A method for making a deer antler wine and a deer antler wine made thereby are also disclosed. | 2012-06-28 |
20120164270 | Yeast Strain and Method for Using the Same to Produce Nicotinamide Riboside - The present invention embraces a fungal strain deficient in nicotinamide riboside import and salvage and use thereof for producing nicotinamide riboside. Methods for producing nicotinamide riboside and a nicotinamide riboside-supplemented food product using the strain of the invention are also provided. | 2012-06-28 |
20120164271 | AUXILLARY ENZYME FOR YEAST, ENZYME DOUGH, BREWING DOUGH AND BREAD, BUN, STEAMED ROLL, BAGEL, METHOD FOR BREWING XIAO BAN ENZYME - A fermentation method using an auxiliary enzyme for yeast, enzyme dough, brewing dough and bread, bun, steamed roll, bagel and a method for brewing xiao ban enzyme, and a method for making enzyme yeast are disclosed. The fermentation method includes using xiao ban dough, vegetable and fruit, whole grains and nuts. Xiao ban dough is the fundamental fluid with overall ratio of 3%˜300%. The method for making auxiliary enzyme for yeast includes using vegetable and fruits, whole unlit) and various nuts, and mixing with xiao ban dough. The duration of fermentation process is between 0-90 days, and the fermentation temperature is between 5 Degree Celsius to 30 Degree Celsius. The auxiliary enzyme for yeast can efficiently enhance food color, odor and taste and prolong food preservation. | 2012-06-28 |
20120164272 | BAKING ENZYME COMPOSITION AS SSL REPLACER - The present invention relates to a baking enzyme composition comprising a lipolytic enzyme having activity on triglycerides, phospholipids and galactolipids, a triacyl glycerol lipase, and preferably at least another enzyme selected from a hemicellulase or cellulase and an amyloglucosidase which can be used to fully replace SSL and/or CSL or other emulsifiers in dough and baked products. The dough in which the baking enzyme composition is added in an effective amount and baked product obtained therefrom have improved properties such as excellent dough stability and shock resistance, and improved volume, crumb structure and crumb softeness of the baked product as well as improved anti staling. | 2012-06-28 |
20120164273 | METHOD FOR PRODUCING PASTEURIZED FRESH CHEESE - An object is to provide a pasteurized fresh cheese which has a smooth texture and a good taste, shows little water release, scarcely shows a lowering in pH or acidity and has a long best-before period. | 2012-06-28 |
20120164274 | FERMENTED DAIRY PRODUCT - The present invention provides a fermented dairy product wherein the acidification rate of a yogurt starter culture and the survival rate of an optionally further present probiotic bacteria are enhanced by the presence of a helper strain. The helper strain is a bacterial strain capable of reducing the redox potential (Eh) of sterilized skim milk to −50 mV or lower (more negative) values upon incubation of sterilized skim milk with said helper strain for 5-24 hours at 25-45° C,. Further advantageously, the inoculation rate of an optional probiotic culture needed for producing the fermented dairy product and comprising desirable levels of viable bifidobacteria—even at the end of its shelf life—is significantly reduced. The fermented dairy product especially relates to a yoghurt-type product. | 2012-06-28 |
20120164275 | LACTIC BACTERIUM WITH MODIFIED GALACTOKINASE EXPRESSION FOR TEXTURIZING FOOD PRODUCTS BY OVEREXPRESSION OF EXOPOLYSACCHARIDE - The present invention relates to a bacterial cell with texturizing property, starter cultures comprising the cell, and dairy products fermented with the starter culture. | 2012-06-28 |
20120164276 | Dressing - Bound salads and other food products can enjoy decreased separation with the addition of a source of glucomannan, especially at from 0.1 wt % glucomannan and higher. Glucomannan absorbs substantial amounts of moisture released by the inclusions such as tuna fish, potatoes, vegetables etc, and as such, prevents “watering out” of the salad. Moreover, glucomannan is resistant to certain enzymes released by the inclusions such as carrots, cabbage, vegetables, fruits etc. Particularly important in this respect are amylases. By virtue of its resistance to amylase, glucomannan can thicken dressings in light products such as light mayonnaise, which often include starches subject to degradation by amylase, with little or minimal “watering out” in extended use. | 2012-06-28 |
20120164277 | DAIRY CONTAINING BEVERAGES WITH ENHANCED FLAVORS AND TEXTURES AND METHODS OF MAKING SAME - The present embodiments generally relate to beverages with enhanced flavors and aromas and method of making same. Some embodiments of the present disclosure are directed to shelf-stable dry dairy products which create foam upon mixing with liquid. Other embodiments are related to beverages with shelf-stable dairy products and soluble coffee. Also disclosed are methods of making the same. | 2012-06-28 |
20120164278 | SYSTEM AND METHOD FOR DETECTION OF A CONTAMINATED BEVERAGE - A system and method for a beverage container configured to test for a contaminated beverage in the beverage container comprises a base of the beverage container, an upper portion of the beverage container, and a sidewall with an inner surface and an outer surface that extends from the base to the upper portion, and a testing material. A portion of the beverage container is the testing material configured to visibly react when the portion of the beverage container is contacted with the contaminated beverage. | 2012-06-28 |
20120164279 | SYSTEM AND METHOD FOR DETECTION OF A CONTAMINATED BEVERAGE - A system and method for a beverage container configured to test for a contaminated beverage in the beverage container comprises a base of the beverage container, an upper portion of the beverage container, and a sidewall with an inner surface and an outer surface that extends from the base to the upper portion, and a testing material. A portion of the beverage container is the testing material configured to visibly react when the portion of the beverage container is contacted with the contaminated beverage. | 2012-06-28 |
20120164280 | Multiple-Region Candy and Manufacturing Method Therefor - Disclosed is a candy wherein loss of a soft component contained therein is minimized, allowing the benefits of the soft component to be enjoyed, and a feeling of roughness in the mouth is reduced. Also disclosed is a method for manufacturing said candy. The disclosed candy ( | 2012-06-28 |
20120164281 | Packaged fresh diced garlic and process for making same - Ready-to-use, fresh diced garlic that has been washed and sanitized and disposed in a container from which gas can escape. | 2012-06-28 |
20120164282 | Light Glaze for Popcorn - Disclosed are microwave popcorn articles comprising any conventional microwave popcorn bag, and a food charge disposed therein comprising kernel popcorn, fat, salt and sufficient amounts of a heat tolerant glaze forming carbohydrate ingredient such as isomalt to provide the finished popped popcorn with sweet glaze coating. Methods of preparing such microwave popcorn articles are disclosed wherein the isomalt in particulate form in a separate step and preferably after the kernel popcorn and fat have been added to the bag. | 2012-06-28 |
20120164283 | Container Lid Having Selectively Coverable Access Opening - A lid is provided that includes an access opening in a top wall thereof selectively coverable by a pivotable cover. The lid attaches to a foodstuff container and provides access to an interior of the container. The lid achieves this without requiring removal of the lid while also providing an impeded foodstuff dispense path having greater control. The cover pivots between open and closed positions, and in one form, can be secured in one or both positions. This can be achieved by releasably securing the cover to the top wall to hold the cover in the closed position and/or capturing a tab of the cover within a depression in an edge portion of the lid to hold the cover in the open position. The cover can further be integrally attached to the lid so that the cover is generally coplanar with the top wall when in the closed position. | 2012-06-28 |
20120164284 | FOLDED DUAL SPLIT PACKAGE - The present invention provides a package assembly for enclosing and dispensing a plurality of consumable products. The package assembly includes a package housing defining a pair of product pockets each having an open end for removably accommodating a plurality of products in an aligned array. The open ends of the pockets are in facing orientation. The package housing includes a fold line between the open ends of the pocket for folding the housing thereat and placing the pockets in an angled orientation for dispensing of product. The housing further defines at least one openable flap for overlying and enclosing the pockets. | 2012-06-28 |
20120164285 | PROCESS AND MULTIPLE PUMP APPARATUS FOR CONTROLLING THE PREPARATION OF BEVERAGES - A dispensing apparatus for hot beverages is provided with means ( | 2012-06-28 |
20120164286 | SOLID-PHASE MICROEXTRACTION COATINGS AND METHODS FOR THEIR PREPARATION - There is described a coated solid phase microextraction (SPME) fibre for use in direct immersion SPME of a food matrix that includes carbohydrates. The coated SPME fibre includes a SPME fibre for absorbing a small molecule from the food matrix; and a protective coating which has a surface that is substantially uniform and substantially smooth, the protective coating reducing adsorption of the carbohydrates onto the SPME fibre and allowing the SPME fibre to extract the small molecule from the food matrix. A process for producing the coated SPME fibre and a method of performing solid phase microextraction are also described. | 2012-06-28 |